All Journals from Ascanio Tridente
Acute Medicine Journal is evolving, in a move to prioritize the publication of more randomized controlled trials (RCTs) and large prospective cohort studies, therefore accepting fewer case reports and retrospective studies. This trend reflects a fundamental shift towards stronger, more reliable and more generalisable scientific evidence in clinical research and practice.
Over the current and subsequent few financial years, a set of significant changes will be implemented affecting the research landscape in the United Kingdom. On the 22nd of September 2025 NHS England released the paper “Increasing research activity in the NHS”1. This paper highlights the clear ambitions of decreasing trial set up times, from the current 250 to under 150 days, while doubling commercial interventional trial participants by 2026 and again by 2029 in the UK. The paper also reveals the UK’s aspiration to become a more attractive Country for international research and commercial investments from the biotechnology industry sector. The plan builds on the Government’s “Life Science Sector Plan”2, published in July 2025, which followed “Fit for the Future: 10 Year Health Plan for England”3. The government has consistently highlighted a commitment for the NHS to support the life sciences industry in the UK. Importantly, research performance will be monitored at both aggregate and individual site level. Furthermore, each NHS organisation’s research budget will be allocated based on historical performance, number of studies and recruitment activity (with weighting based on the type of study), and new performance, including study set up times, efficiency of delivery and commercial research activity expansion.